Frontal lobe epilepsy (FLE) surgery is the second most common surgery performed to treat pharmacoresistant epilepsy. Yet, little is known about long-term seizure outcome following frontal lobectomy. The aim of this study is to investigate the trends in longitudinal outcome and identify potential prognostic indicators in a cohort of FLE patients investigated using modern diagnostic techniques. We reviewed 70 patients who underwent a frontal lobectomy between 1995 and 2003 (mean follow-up 4.1 6 3 years). Data were analysed using survival analysis and multivariate regression with Cox proportional hazard models. A favourable outcome was defined as complete seizure-freedom, allowing for auras and seizures restricted to the first post-operative week. The estimated probability of complete seizure-freedom was 55.7% [95% confidence interval (CI) = 50-62] at 1 postoperative year, 45.1% (95% CI = 39-51) at 3 years, and 30.1% (95% CI = 21-39) at 5 years. Eighty per cent of seizure recurrences occurred within the first 6 post-operative months. Late remissions and relapses occurred, but were rare. After multivariate analysis, the following variables retained their significance as independent predictors of seizure recurrence: MRI-negative malformation of cortical development as disease aetiology [risk ratio (RR) = 2.22, 95% CI = 1.40-3.47], any extrafrontal MRI abnormality (RR = 1.75, 95% CI = 1.12-2.69), generalized/non-localized ictal EEG patterns (RR = 1.83, 95% CI = 1.15-2.87), occurrence of acute postoperative seizures (RR = 2.17, 95% CI = 1.50-3.14) and incomplete surgical resection (RR = 2.56, 95% CI = 1.66-4.05) (log likelihood-ratio test P-value < 0.0001). More than half of patients in favourable prognostic categories were seizure-free at 3 years, and up to 40% were seizure-free at 5 years, compared to <15% in those with unfavourable outcome predictors. These data underscore the importance of appropriate selection of potential surgical candidates.
Introduction
Frontal lobe epilepsy (FLE) surgery accounts for 6-30% of all epilepsy surgeries. It represents the second most common procedure performed to treat pharmacoresistant epilepsy after temporal lobectomy (Janszky et al., 2000; Hosking, 2003) . Reported success rates range from 13 to 80% (Rasmussen, 1991; Talairach et al., 1992; Fish et al., 1993; Wieser and Hajek, 1995; Zentner et al., 1996; Swartz et al., 1998; Ferrier et al., 1999 Ferrier et al., , 2001 Jobst et al., 2000; Mosewich et al., 2000; Zaatreh et al., 2002; Chung et al., 2005; Lee et al., 2005; Yun et al., 2006) , suggesting much less rewarding outcomes than following temporal lobectomy (Talairach et al., 1992; Fish et al., 1993; Wieser and Hajek, 1995; Jeha et al., 2006) . However, surgical failures remain poorly characterized.
Most prior reports included patients with other types of neocortical epilepsy in addition to FLE limiting the applicability of their results in patients with pure FLE (Zentner et al., 1996; Lee et al., 2005; Yun et al., 2006) . Some restricted their analysis to lesional FLE (Janszky et al., 2000; Schramm et al., 2002; Zaatreh et al., 2002) introducing a selection bias, especially since current literature suggests that lesional epilepsy patients have better outcomes (Ferrier et al., 1999; Mosewich et al., 2000; Yun et al., 2006) . Several older studies were done in the pre-MRI era (Rasmussen, 1991; Talairach et al., 1992; Fish et al., 1993; Wieser and Hajek, 1995) , a significant limitation as neuroimaging seems to be a very important determinant of post-operative seizure-freedom (Smith et al., 1997; Ferrier et al., 1999; Mosewich et al., 2000; Kral et al., 2001; Yun et al., 2006) . Few studies attempted to evaluate predictors of recurrence using multiple logistic regression methods to account for interaction among outcome indicators (Janszky et al., 2000; Mosewich et al., 2000; Yun et al., 2006) , but all were cross-sectional in design. Thus, none evaluated longitudinal aspects of recurrence such as the change in rate of post-operative seizure-freedom with time, nor investigated potential prognostic predictors using modern statistical techniques designed for time-dependent variables and outcomes. With current knowledge, it is therefore difficult to predict long-term seizure-freedom following frontal lobectomy, and to correctly identify independent predictors of outcome.
The goal of our study is to examine seizure-freedom following frontal lobectomy in a cohort of FLE patients evaluated using modern diagnostic techniques. In particular, we aim at assessing the chances and predictors of long-term post-operative seizure-freedom. We used the statistical methods of survival analysis and proportional hazard modelling to evaluate rate, stability and predictors of seizurefreedom while accounting for variation in the duration of follow-up among patients.
Material and methods

Patient selection
We reviewed medical records of all patients with medically refractory FLE who underwent frontal lobectomy at Cleveland Clinic between January 1995 and December 2003, excluding those with prior brain surgery, or with resections extending beyond the frontal lobe. Follow-up of at least 1 year was required. Data collected included dates of surgery, of seizure recurrence and of last follow-up, age at seizure onset and at surgery, gender, side of surgery, presence of auras and of generalized tonic-clonic seizures, family history of epilepsy, seizure semiology and frequency, and results of pre-operative and post-operative EEG and MRI. The occurrence of acute post-operative seizures (APOS) as defined by seizures occurring within the first post-operative week was also recorded.
Pre-operative patient evaluation protocol
All patients had prolonged video-EEG monitoring with electrodes placed according to the International 10-20 system. Interictal discharges were classified as either strictly frontal or not. The presence of additional contralateral, generalized or focal extrafrontal spikes was noted. EEG ictal patterns were categorized as regional if the EEG seizure amplitude in one chain was at least twice as high as the adjacent bipolar electrode chain. A lateralized pattern was defined if both ipsilateral electrode chains were involved and the contralateral hemisphere pattern was <50% amplitude. If a clear side of onset was not present, or if the initial EEG change was diffuse, the seizure was defined as non-localizable or generalized. Clinical seizure semiology was recorded (Luders et al., 1998) , as was the occurrence of multiple seizure types. All patients had high-resolution MRI performed with a Siemens 1.5 tesla SP system (Siemens, Erlangen, Germany) using a standardized epilepsy protocol that included high resolution T 1 -weighted volume acquisition, T 2 -weighted and fluid attenuated inversion recovery sequences. Patients were classified as either having a normal MRI, pure frontal lobe abnormalities or lesions extending beyond the operated frontal lobe. The presence of associated hippocampal atrophy and/or hippocampal signal changes suggestive of hippocampal sclerosis was noted separately.
Additional functional neuroimaging studies (PET and SPECT) were obtained when indicated. All patients had detailed neuropsychological and psychosocial evaluations. Results of the noninvasive evaluation were discussed in a multidisciplinary patient management conference where the decision was made to either proceed with surgery, or to perform an invasive evaluation for further investigation. Subdural electrodes (SDE) were implanted for any of the following reasons: (i) to confirm the ictal onset zone if scalp EEG information was either non-localizing or inconsistent with other non-invasive investigations such as MRI or seizure semiology; (ii) to perform functional mapping pre-operatively if the ictal onset zone was thought to be close to eloquent cortex; (iii) whenever a multifocal epileptogenic process was suspected based on multifocal non-invasive EEG findings or multilobar involvement on imaging. Intraoperative electrocorticography (EcoG) was performed in some cases to either confirm removal of epileptogenic cortex, or to avoid eloquent cortex resection. The occurrence of multifocal seizures on invasive evaluation was recorded.
Surgery and pathological subgroups
All patients underwent lesionectomy, subtotal lobectomy or frontal lobectomy. We did not include cases of hemispherectomy or patients with previous epilepsy surgery. The posterior resection margin was determined by the precentral sulcus as defined anatomically and by invasive recordings to avoid loss of eloquent cortex.
Tissue sections from cortical resections were fixed in 10% buffered formalin, embedded in paraffin and then stained. Pathological diagnoses were classified into malformation of cortical development (MCD, cortical dysplasia), neoplasm, gliosis, vascular malformation or normal histology.
Based on MRI and surgical pathology, patients were divided into the following aetiological subgroups: (i) MCD with abnormal MRI (41% of cases), (ii) MCD with normal high-resolution MRI (17%), (iii) tumour (19%), (iv) vascular malformation (3%), (v) cryptogenic with normal MRI and histology (10%), (vi) encephalomalacia following stroke or trauma (10%).
Post-operative patient evaluation protocol
Post-operatively, patients were admitted to the general neurology floor, neurology intensive care unit or epilepsy monitoring unit. All patients underwent a post-operative high-resolution MRI, and a routine outpatient EEG at 6 post-operative months. A judgement was made as to whether surgical resection was complete. In nonlesional cases (n = 18), resection was considered complete if there was complete removal of the brain tissue covered by the electrodes of ictal onset and most frequent interictal abnormalities defined by invasive electrophysiological evaluations. In lesional cases (n = 51), complete removal of the MRI lesion was required. In patients with a lesional MRI, who also had SDE or EcoG (n = 29), complete resection of electrophysiological abnormalities was required in addition to removal of the MRI abnormality.
Outcome definition
Patients were classified as either seizure-free or not seizure-free. The 'seizure-free' definition encompassed auras and seizures restricted to the first post-operative week. Follow-up information was obtained from clinic visits and patient phone calls. The typical follow-up schedule consisted of a clinic visit at 3 post-operative months, 6 months, 1 year and then yearly or as indicated. The primary outcome was time to first seizure recurrence. In patients who had APOS within the first post-operative week, the time to the first recurrence following the APOS was considered. When medical records indicated that a recurrence occurred between two follow-up visits or phone contacts, the date of recurrence was taken as the mid-point of this period. With all patients having the follow-up schedule detailed above, the period between documented contacts (visits or phone calls) never exceeded 1 year.
Statistical methods
Prior to modelling, the data were summarized with descriptive statistics for each variable including means, medians, and standard deviations for continuous variables and frequencies for categorical variables. For exploratory purposes, an initial analysis of the data was first performed univariably using Wilcoxon rank sum, x 2 and Fisher's exact tests to compare seizure-free patients to those with seizure recurrence, regardless of follow-up time. This allowed identification of potential prognostic indicators. Variables with a significance level of 10% on initial univariate analysis were then tested in a multivariate Cox proportional hazards regression model. Results were then considered statistically significant at the 5% level. This method allows testing the correlation of specific variables with outcome while taking into account any interactions and associations among those variables, and their variation with time.
Kaplan-Meier survival analysis was first used to calculate the probability of seizure-freedom in the overall group prior to any outcome predictor analysis, and later by considering each of the significant risk factors. Statistical significance was tested using the log-rank test and comparison of 95% confidence intervals (CIs).
Results
Patient characteristics
Seventy patients fulfilled all inclusion and exclusion criteria and were analysed. The mean follow-up duration was 4.1 years 6 (SD) 3.0 years (median 3.1; range 1-11 years). Seizures recurred in 39 patients (56%) by the time of last follow-up. Only 4/39 recurrences (10%) occurred in the context of AED withdrawal. Table 1 summarizes the patients' baseline clinical characteristics, while Table 2 describes their imaging characteristics.
Forty-three per cent were females, about half had left sided surgery and a third had multiple clinical seizure types. Most had abnormal neuroimaging: only 18 (26%) had a normal MRI and 24% had a normal PET (9 out of 37 where PET was performed). Among 22 patients with multilobar MRI findings, 8 had 'dual pathology' with hippocampal atrophy and/or hippocampal signal changes: five of those had evidence of frontal cortical migrational abnormalities on MRI, two had a frontal lobe tumour and one had frontotemporal encephalomalacia.
On non-invasive recordings, EEG abnormalities were mostly frontal, although diffuse changes were frequent (Table 3) . Interictal spiking was strictly frontal in 46 (68%), with generalized spikes in another 17 (25%). Regional frontal EEG seizures were recorded in 36 cases. Multiple EEG seizure types were captured in 17 (25%). Ipsilateral spiking was seen in 32 out of 61 patients who had a 6 month post-operative EEG. SDEs were often used (47 patients or 67%). All patients with traumatic encephalomalacia and those eventually diagnosed with MRI-negative MCD had SDE evaluation, followed by 62% of lesional MCD cases and 23-50% of cases with other aetiologies. Intraoperative EcoG was performed in 78% of patients who did not have SDE, and in 60% of those who did. With invasive EEG recordings, multifocal seizures were recorded in 14/47 cases (30%) ( Table 3) .
Surgical resection was felt to be complete in 42 (60%) of the cases. Most incomplete resections were to avoid removal of eloquent cortex. Twenty patients (29%) had APOS. Postoperative auras occurred in 26: auras remained isolated in 4 and were associated with seizures in 22.
Overall recurrence
The Kaplan-Meier survival curve illustrating seizure recurrence in the overall group is shown in Fig. 1 . Although 39 patients (56%) had seizure recurrence by the time of last follow-up, it is clear from Fig. 1 that the chance of being seizure-free varied widely with post-operative time. The chance of seizure-freedom fell abruptly to 56% within the first 6 months, then at a somewhat slower rate (5-8% per year) until 4-5 years, beyond which it stabilized at around 30%. In fact, the median timing of seizure recurrence was 2 months with 80% of recurrences occurring before 6 months. The estimated chance of seizure-freedom was 55.7% (95% CI = 50-62) at 1 post-operative year, 50.5% (95% CI = 44-56) at 2 years, 45.1% (95% CI = 39-51) at 3 years, 37.6% (95% CI = 31-44) at 4 years and 30.1% (95% CI = 21-39) at 5 years and beyond. Table 4 shows the outcomes using Engel's criteria at 1, 2 and 5 years post-operatively. In addition to 38 patients who were completely seizure-free at 1 year, 17 had a significant improvement in seizure control (Engel 2 in 9, and Engel 3 in 8 patients): mean monthly seizure frequencies dropped from 124.4 6 21.4 seizures down to 19.8 6 38.7 in this subgroup. However, this improvement was sustained until the last follow-up in only 6/17 (35%), with seizure frequencies returning to pre-operative levels in the remainder. Even among the seven patients who only had rare breakthrough seizures (<1 per month) within the first year, seizures worsened in six (median 18 seizures/month; range 1-150 at last follow-up) despite re-operation in three and anticonvulsant adjustment in all.
Late relapses after early seizure-freedom were observed, but were rare. Only eight patients relapsed after being seizure-free for the first 6 months. Those patients tended to have less frequent seizures at last follow-up compared to those with recurrences within the first 6 months (median 12 seizures/month; range 0-120 at last follow-up if first recurrence after 6 months compared to 30 seizures/month; range 0-300 if first recurrence was earlier; P = 0.10). In fact, Outcome
half of those eight patients achieved Engel 1 class again by last follow-up: two had an isolated breakthrough seizure when off AEDs and were controlled again with re-initiation of AEDs, and two were controlled after re-operation. For the 39 patients with any seizure recurrence, the Engel classification at last follow-up was 1 in 7 (18%), 2 in 6 (15%), 3 in 11 (28%) and 4 in 15 (38%). Therefore, even following seizure recurrence, 62% of patients were significantly improved at last follow-up compared to baseline: half of those, however, were only controlled following re-operation.
Univariate analysis
On initial univariate screening, the following variables correlated with seizure recurrence: MRI-negative MCD as disease aetiology, hippocampal atrophy (dual pathology) or any extrafrontal abnormality on MRI, generalized/nonlocalized ictal patterns and interictal discharges on scalp EEG, need for SDE implantation, occurrence of APOS, postoperative auras and incomplete surgical resection (Table 5) . The independence and significance of those variables was assessed in the multivariate proportional hazard model.
Ipsilateral interictal spiking on the 6 months postoperative routine EEG was more frequent in patients with a bad outcome (Table 3) . Even though 80% of recurrences had already occurred by 6 post-operative months, univariate survival analysis showed that ipsilateral spikes correlated with future recurrence in the subgroup of patients who were still seizure-free up to that point (Table 6 ). However, the numbers were too small to include this variable in a multivariate analysis.
Multivariate analysis
Upon applying proportional hazard modelling, the following variables retained their significance as independent predictors of outcome: MRI-negative MCD as disease aetiology, any extrafrontal MRI abnormality, generalized/non-localized ictal EEG patterns, occurrence of APOS, and incomplete surgical resection (log likelihood-ratio test P-value <0.0001). Results are shown in Table 7 . The use of SDE, generalized interictal discharges and presence of postoperative auras lost their significance. Upon further analysis, we found that the use of SDE correlated both with a normal MRI (P = 0.0126, Pearson x 2 test), and with a pathological diagnosis of MCD (P = 0.0004). Generalized interictal discharges were more frequent in patients where a complete resection could not be achieved (P = 0.0139). Post-operative auras correlated strongly with MRI-negative MCD as disease aetiology (P = 0.0255), and weakly with incomplete resection (P = 0.0648). No correlation was identified between postoperative auras and the presence of extrafrontal MRI abnormalities on pre-operative testing.
Seizure-free rates for the identified outcome predictors were calculated at 1, 2 and 3 post-operative years (Table 8) , and survival analysis curves were constructed (Fig. 2) . All patients with MRI-negative MCD as disease aetiology or with APOS had seizure recurrence before 3 post-operative years. In those with extrafrontal MRI abnormalities, generalized/non-localized ictal EEG patterns or incomplete resection, chances of seizure-freedom stabilized within the 11-14% range beyond 3 post-operative years.
When disease aetiology or completeness of surgical resection are considered, the magnitude of the difference in outcome between the favourable and unfavourable groups is appreciable as early as the first post-operative year landmark. At 1 year, only 12% of patients with MRI-negative MCD and 13% of those with incomplete resection were seizure free, as opposed to 64 and 81%, respectively, in the corresponding better prognosis groups. Eventually, the chances of seizure-freedom were much higher in the favourable prognosis groups (50-66% at >3 years) compared to the bad prognosis groups (0-14% at >3 years) for all variables. Thirteen patients fulfilled all the favourable prognostic requirements (i.e. had strictly frontal MRI lesions judged to be completely resected, with focal preoperative ictal EEGs and no APOS). Of those, only two (15%) had seizure recurrences during the whole duration of follow-up. The extent of surgical resection was the strongest predictor of outcome [risk ratio (RR) = 2.56, 95% CI = 1.66-4.05].
Discussion
Overall seizure recurrence
We report the first longitudinal outcome study on 70 FLE patients evaluated using modern diagnostic techniques. Previously reported rates of seizure-freedom following FLE surgery varied greatly from as low as 13% to as high as 80% (Rasmussen, 1991; Talairach et al., 1992; Fish et al., 1993; Wieser and Hajek, 1995; Zentner et al., 1996; Swartz et al., 1998; Ferrier et al., 1999 Ferrier et al., , 2001 Jobst et al., 2000; Mosewich et al., 2000; Zaatreh et al., 2002; Chung et al., 2005; Lee et al., 2005; Yun et al., 2006) . Heterogeneity of patient populations, evolution of surgical techniques and inconsistency of 'favourable outcome' definition among studies may account for such a wide difference. Our data suggest that use of cross-sectional methods of analysis at different points of follow-up might also have contributed to this discrepancy among previous studies. Although 54% of our patients were seizure-free at last follow-up, similar to many recently published reports (Swartz et al., 1998; Wennberg et al., 1999; Janszky et al., 2000; Ferrier et al., 2001; Schramm et al., 2002) , our longitudinal analysis shows that the actual chance of seizure-freedom varies greatly with post-operative time. While 56% of patients were seizure-free at 1 year, only 45% were seizure-free at 3 years, and a mere 30% still enjoyed this seizure-freedom at 5 years. A drop in seizure-freedom with post-operative time has been repeatedly documented following temporal lobectomy (Yoon et al., 2003; McIntosh et al., 2004; Jeha et al., 2006) . Our study shows that it occurs at a higher pace and to a greater extent following FLE surgery: 80% of seizure recurrences occurred within 6 months in our study, while only about half the recurrences following temporal lobe surgery occur within the same timeframe (Luders et al., 1994; Sperling et al., 1996; Foldvary et al., 2000) . Recurrences were also more difficult to control in our FLE patients. While resumption of AEDs controls up to 60% of post-operative recurrences after temporal lobectomy (Schmidt et al., 2004; Jeha et al., 2006; Schwartz et al., 2006) , seizures persisted in at least 60% of our recurrences at last follow-up.
Although only one third of our overall cohort enjoyed long-term seizure-freedom (Fig. 1) , this is probably due to the wide difference in outcome among patients with favourable prognostic indicators compared to those without them, rather than due to inadequacy of surgery as such to treat refractory FLE. For all the prognostic indicators we identified, more than half of patients in the favourable categories were seizure-free at 3 years, and up to 40% were seizure-free at >5 years (Fig. 2) . Those are acceptable outcomes, albeit still less favourable than the 40-55% seizurefreedom rates proposed at 10 years following temporal lobectomy (Foldvary et al., 2000 MCD (normal MRI) (P = 0.0009) Yes 12 6 8 86 7 N/A No 64 6 6 5 86 7 5 36 7 Extrafrontal MRI abnormalities (P = 0.02) Absent 60 6 7 5 76 7 5 76 7 Present 45 6 11 28 6 10 14 6 9 Immediate post-operative seizures (P < 0.0001) Absent 67 6 7 6 36 7 5 76 7 Present 38 6 11 20 6 9 N/A Ictal EEG (P = 0.01) Regional/lateralized 57 6 7 5 06 7 5 06 7 Generalized 33 6 12 22 6 12 11 6 9 Extent of resection (P < 0.0001) Complete 81 6 6 7 06 7 6 66 7 Incomplete 13 6 7 1 26 6 1 16 6 Jutila et al., 2002; McIntosh et al., 2004; Kelley and Theodore, 2005; Jeha et al., 2006) . When patients fulfilled all our favourable indicators, the chance of seizure-freedom was 85% at last follow-up, similar to success rates following temporal lobectomy. This suggests that even in FLE, very successful outcomes can be achieved in a highly selected group of patients.
Predictors of outcome
We identified five predictors of outcome. For all, the chance of seizure-freedom was >50% at 3 years in the favourable categories, while <15% of patients were estimated to be seizure-free otherwise. All prognostic factors converge into one central theme: an epileptogenic zone that is well visualized and restricted in its extent (both electrically and semiologically) offers the best chances of cure when completely resected. Factors that either reflect poor visualization of the epileptogenic zone (MRI-negative MCD), or its diffuse extent (extending beyond the frontal lobe on MRI, and showing generalized/non-localized ictal pattern) make a 'complete' removal of epileptogenic brain tissue harder, and characterize the patient population at highest risk of recurrence. The occurrence of APOS, a poor prognostic marker for our patients, may then represent an immediate post-operative correlate of residual epileptogenicity following an incomplete resection.
Pre-operative clinical predictors
Similar to previous reports, we found no correlation of postoperative seizure outcome with gender (Yun et al., 2006) , side of surgery (Olivier, 1995; Schramm et al., 2002; Yun et al., 2006) , age at onset of epilepsy (Ferrier et al., 1999; Janszky et al., 2000; Schramm et al., 2002; Lee et al., 2005; Yun et al., 2006) , age at surgery (Schramm et al., 2002; Lee et al., 2005; Yun et al., 2006) , epilepsy duration (Ferrier et al., 1999; Janszky et al., 2000; Lee et al., 2005; Yun et al., 2006) , pre-operative seizure frequency, history of generalized tonic-clonic seizures (Ferrier et al., 1999; Chung et al., 2005; Yun et al., 2006) , multiple clinical seizure types or auras (Yun et al., 2006) , nor family history of epilepsy.
Imaging predictors
Our finding that a MRI-visible frontal lobe lesion correlates with post-operative seizure-freedom is consistent with current literature (Cascino et al., 1992; Smith et al., 1997; Ferrier et al., 1999; Mosewich et al., 2000; Kral et al., 2001; Yun et al., 2006) . Twenty-five per cent of the patients with negative MRI studies and 67% of those with neuroimaging abnormalities restricted to the frontal lobe were seizure-free at a minimum duration of 1 year follow-up in one study (Cascino et al., 1992) . A focal MRI abnormality was the only variable significantly associated with a favourable surgical outcome in another report (Ferrier et al., 1999) . Only 41% of non-lesional FLE patients had an excellent outcome, versus 72% when MRI abnormality was present in yet another analysis (Mosewich et al., 2000) . A normal MRI in a patient with 'apparent' FLE could mean that either the true epileptogenic zone is extrafrontal and not visible on MRI, or that the focus is indeed frontal, but invisible on imaging. In either case, post-operative seizure-freedom would not be very likely. In our cohort, a poor prognosis was seen in patients with normal MRI and pathologically proven MCD (RR = 2.22, 95% CI = 1.40-3.47). All such patients had recurrent seizures by 3 postoperative years. This is consistent with many recent reports. Among all MCD patients, a mild degree of dysplasia and a frontal lobe location were the only variables predictive of a poor outcome in a study where 68.8% of frontal lobe MCD cases actually had normal imaging . Concurrently, among all neocortical epilepsies, a frontal lobe location and MCD predicted the worst outcomes in another report (Yun et al., 2006) . Knowing that milder forms of MCD subtypes such as microdysgenesis, cortical dyslamination or focal MCD are often missed, even on high-resolution MRI (Lee et al., 2001; Montenegro et al., 2002; Tassi et al., 2002; Widdess-Walsh et al., 2005) may explain why one cannot 'see' the extent of the epileptogenic tissue in those MRInegative MCD cases making adequate surgical treatment harder. Tumours, well-circumscribed pathologies, had the best outcome in our cohort (62% seizure-free at last followup, Table 5 ).
Any extrafrontal MRI abnormality conferred poor prognosis, similar to previous reports (Cascino et al., 1992; Salanova et al., 1994; Lorenzo et al., 1995; Swartz et al., 1998; Wyllie et al., 1998; Ferrier et al., 1999; Schramm et al., 2002) where favourable outcomes occurred in either none of the patients with multilobar MRI abnormalities (Cascino et al., 1992; Lorenzo et al., 1995) , or at best in 10-14% (Swartz et al., 1998; Schramm et al., 2002) . Some investigators have specifically suggested that the structural basis of all or some of the intractable seizures following failed FLE surgery may be undetected mesial temporal sclerosis (MTS) because a history of childhood febrile seizures was a poor prognostic factor for their patients (Mosewich et al., 2000) . In our group, eight patients (12%) had 'dual pathology' on MRI. This is within the 0-29% previously reported incidence of dual pathology with extratemporal refractory epilepsy (Cascino et al., 1993; Adam et al., 1994) . It is however less than the 40% rate reported in MCD series, where its occurrence was virtually restricted to TLE patients (Li et al., 1999; Fauser et al., 2006) . Outcomes of 'dual pathology' patients in our series (13% seizure-free at last follow-up, Table 5 ) are concordant with a recent series of 38 'dual pathology' patients (including 8 with frontal lesions), where only 12.5% of those with lesionectomy alone were seizure-free compared to 73% with lesionectomy and mesial temporal resection (Li et al., 1999) . 'Dual pathology' cases in our series did not, however, fare significantly worse than those with other extrafrontal abnormalities (23% seizure-free at last followup, Table 5 ), and the presence of MTS was only significant on the univariate level of analysis suggesting that it may be just as significant as other extrafrontal MRI abnormalities in predicting outcome.
Correct localization by PET predicted surgical success in prior series of neocortical epilepsy Yun et al., 2006) . Also, FDG PET was sensitive in localizing epileptogenic zones in both lesional and non-lesional patients with FLE (Kim et al., 2002) . A predictive value to FDG-PET is therefore very possible in FLE surgery. Our results do not confirm such a correlation (Table 2) . This is either sample-size related or because an independent predictive value of PET does not exist in the specific subgroup of neocortical epilepsy patients with FLE.
Electrophysiological predictors
EEG evidence of diffuse epileptogenicity minimized surgical success rates. Both generalized interictal and ictal EEG correlated with worse outcome on univariate analysis. However, only generalized ictal EEG remained significant after multivariate modelling (RR = 1.83, 95% CI = 1.1.5-2.87). This is consistent with a recent report showing that generalized EEG features (slowing and spikes) were the only predictors of seizure recurrence following surgery for
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Brain (2007), 130, 574-584lesional FLE (Janszky et al., 2000) , and with another study where a localized ictal onset on EEG was an independent predictor of seizure-freedom in a cohort of neocortical epilepsy (Yun et al., 2006) . While previous reports suggested that SDE use either had negative (Armon et al., 1996; Janszky et al., 2000) or no prognostic significance in FLE (Kral et al., 2001; Mariottini et al., 2001; Yun et al., 2006) , our data suggest that it is simply a reflection of a poorly localized epileptogenic zone, rather than an independent predictor of outcome. In our cohort, SDEs were used mostly in patients with a normal MRI who had cortical dysplasia on pathology, the group with the worst surgical prognosis. Patients with multiple EEG seizure types on either invasive or non-invasive recordings tended to have a worse outcome, but this correlation did not achieve statistical significance (Tables 1 and 3 ).
Surgical predictors
The most important factor in determining a favourable outcome in our group was completeness of resection (RR = 2.56, 95% CI = 1.66-4.05). Of patients who had complete removal of their epileptogenic lesions, 81% were seizure-free at 1 year and 66% at 3 years, compared to 13 and 11%, respectively, of those who underwent partial resection. Complete removal of neuroimaging abnormalities (Awad et al., 1991; Wennberg et al., 1999; Janszky et al., 2000; Tassi et al., 2002; Urbach et al., 2002; Chung et al., 2005) , and abolition of residual EcoG spiking (Salanova et al., 1994; Tran et al., 1997) or seizures (Ferrier et al., 2001) have already been linked with the most favourable outcomes following FLE surgery. Those findings are not surprising: it is only logical to expect that 'complete' removal of the epileptogenic tissue should lead to seizure-freedom. The first caveat in this regard is assessing the 'completeness' of the resection: we now know that histological abnormalities in MCD, the main pathological substrate of FLE, frequently extend beyond the visible MRI changes (Palmini et al., 1991 (Palmini et al., , 1994 . Removing the radiological abnormalities is therefore no guarantee that the residual tissue is all normal. Standardization, cost-effectiveness and extent of additional information provided by intraoperative EcoG to ensure 'complete' removal of any epileptogenic tissue remain to be defined in FLE (Ferrier et al., 2001) . The second caveat is that even when an epileptogenic lesion is well-delineated, 'complete' resection may not be possible because of frequent overlap with eloquent cortex in the frontal lobe.
Post-operative predictors
A poorly understood prognostic indicator has traditionally been the presence of APOS. In our series, APOS occurred in 20 patients (29%), of whom 16 (80%) developed persistent seizures. While many studies evaluating seizures within 1 week following temporal lobectomy uniformly showed worse outcomes (Garcia et al., 1991; Luders et al., 1994; Salanova et al., 1996; Malla et al., 1998; Radhakrishnan et al., 2003; Spencer et al., 2005) , only one study to date assessed the significance of APOS following FLE surgery (Tigaran et al., 2003) . Contrary to our finding that APOS predict seizure recurrence (RR = 2.17, 95% CI = 1.50-3.14), Tigaran et al. found that FLE patients who had APOS had a seizurefree outcome similar to that of individuals without APOS, but appeared less likely to have a favourable outcome (i.e. fewer than 3 seizures/year and >95% decrease in seizure activity). Their results may not have reached statistical significance because of small sample size, or alternatively because their study evaluated outcome at last follow-up only and controlled for age, sex, presence of APOS risk factors and surgical complications but not other predictors of outcome after FLE surgery such as aetiology and completeness of resection. Data on APOS following temporal lobectomy suggest that they reflect residual epileptogenic tissue (Salanova et al., 1996) , or a more diffuse 'intractability factor' independent of pre-operative pathology type (McIntosh et al., 2005) . The same could apply following surgery for FLE, where epileptogenic processes are even more diffuse. In this study we did not address whether the type of APOS (similar to pre-operative seizures versus atypical seizures) affected outcome.
Post-operative auras were more frequent in surgical failures, but did not achieve statistical significance as an independent predictor of outcome (P = 0.0675). This could be explained by the small sample size and the retrospective study design where the accurate assessment of the onset and timing of subtle aura symptoms is limited. Alternatively, based on their correlation with MRI-negative MCD and incomplete surgical resection in our cohort, one could postulate that such auras simply represent the earliest symptom of a residual diffuse epileptogenic tissue.
Conclusions
We report the first longitudinal outcome study on 70 FLE patients evaluated using modern diagnostic techniques. We show that frontal lobectomy can be a successful treatment option in selected patients with refractory epilepsy, with longterm seizure-freedom rates of up to 40%. Eighty per cent of seizure recurrences occur within the first 6 months following surgery. Ideal surgical candidates are those in whom there is MRI and electrophysiological evidence of epileptogenicity that is restricted to the frontal lobe, and in whom a complete resection of the epileptogenic zone is possible.
